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hlamasiya ~f usan 
dalan akukan swb6 yang 
haws mempanimbangkan misi dari masing-masing p lyanan antara lain pemerintah 
dan swasta. Sehingga perlu diiakukan studi untuk m€ 'sarnya biaya pemulihan yang 
layak sebagai @man untuk penetapan besar tarif c rsing fasiiitas. 
Tujuan dari studi ini adalah untuk mempeMjan ,..,. , Ahan dan Automated Clinical 
Analyzer (ACA) di laboratorium ~ m e h  sakii pemerintl atorium klinik swasta di Jawa 
Timur. 
Sludi ini menerapkan dlstribusi langsung an gga..... ,-;at pembiayaan instifusi yang 
bemangkutan untuk alokasi biaya dalam perhitungan biaya total cast. Biaya total diklasifikasikan 
dalam biaya kapital (capitalccst) dan biaya kembali (recurrwntccst). Ratio biaya pemuiihan dihitung 
dari tofalpendapatan dibagi biaya total. Bile ratio biaya pemulihan kurang dan satu menunjukkan 
bahwa pmvider mengalami kerugian, sebaliknya bila ratio biaya pemulihan lebih dansatu, berarli 
pmvider mendaptkan keuntungan. 
Hasil studi menunjukkan, di kedua Iasilifas pelayanan, blaya kapltal memberi kmtribusi 
terbesar dan' tdal biaya, diikufi blaya mef.9fial dan biaya twnaga. Di laboratorium Nmah saki1 
pemenntah biaya capitalsebesar48,3%, biaya materia144,4% dan biaya tenaga 7.3%. Sedangkan 
dilaboratorium klinikswasta biaya capitalseb6sar53.5%. biaya material31,PA dan biaya tenaga 
14,a%. Dan' biaya kapital, harps pembelian ACA menggunakan p m i  biaya ferbanyal; Biaya 
satuan ram-rata di k e d y  lasilitas masing-masing adalah Rp 7.330 dan Rp. 13.983. Ratio biaya 
pemulihan di laboratorium wmah sekit pe, 9lah 1.22 sedangkan di laboratoriom klinik 
swesta adslah 1.45. Berartl kedua fasililas 9n untung. Tarif rate-ram pameriksaan test 
laboratorium dimmah sakltpsmerintahada 9 dan jumlah pemen'ksaan test laboratorium 
(elah melebihi titik i m p s  (break-even poi!,,, ,,w-. "drankan untuk menuwnkan biaya sebesar 
biaya satuan (Rp. 7.330) menglngat Nmah sakil pemerintah mempunyai misi tidah mengambil 
keunfungan (non-profit). Untuk sekior swasla, keuntungan 20% menrpakan keuntunpen yang 
layak sehingga disdrankan menumnkan laril pemeriksaan sebesar 3% dari taril rala-rata yang 
saat ini adalah Rp. 17.250. Kebijaksanaan penetapan taril juga perlu mempefiimbangkan 
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pengeecualian farlf uunhrk mereka yang membayarlangsvng (dafpocket) dan meraka yang t&k 
mampu membayar pelayanan. 
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INTRODUCTION (29.06% d high 
The use of new medical technology 
tends to increase steadily. It will improve 
the accuracy, specificity and sensitivity of 
this machine producing the precise 
diagnosis. For examples: Utilization of 
Magnetic Resonance Imaging (MRI). 
Computerized Tomography Scanning 
(CT scan). Ultrasonography (USG) and 
Autoanalyzer. It also can improve the 
management of patient's care. 
Due to high capital investment, new 
medical technology will increase the 
health expenditure. The experience in 
developed countries reveal that new 
medical technology contributes up to 
20%-25% of the expenditure of a medical 
care institution '(Feldsteln. 1993). Like 
other countries, Indonesia also needs to 
a! jy that 
h. ! care. 
si ure in 
Inaones~a wntcn 1s lessman 3% or Gross 
Domestic Product (GDP) should not be 
consumed too much for high medical 
technology equipment so that public 
health program (e.g. promotion and 
preventive) could be expanded (MOH. 
1997). 
Automated Clinical Analyzer (ACA) 
is a costly laboratory equipment that has 
more test capability, more investment cost 
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(70.94% of total cost) (PPEKI. 1991). 
resulting cost for every test become 
expensive. To be effective, such 
equipment must be operated, calibrated 
and maintained by trained staff. it also 
involves the use of digital system in which 
the price of the system i.e. the hardware 
and the software are expensive and the 
cost of m :e of the system 
(i.e. replac mponent or spare 
part) is also nlgn. In addition, the use of a 
new medical technology needs a high- 
qualified clinician as well as the support 
infrastructure necessary for continuing 
use of the device, and this will add the 
expenses of medial care. 
There are advantages from this 
machine, such as the machine developed 
rve the outcome of 
?d one operator or 
recnnlclan ro operate so the labor cost 
n which 
un; and 
3sult can 
BChleVe more raster. ~ n e  accuracy, 
precision and sensitivity of this machine 
were show excellent performance than 
the manual method (Las Heras et el, 
1993, Ban Naoul eta1 1993. Flood ef el, 
1990). From an exploration study of 
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Autoanalizer at 3 cllnlcal laboratories in 
Surabaya, using cross sectional data by 
Sumodinoto et al(1997), revealed that the 
price of Autoanalyzer range between 
Rp. 60 Million (US5 24,000 ) to Rp. 215 
Million (US$86,000), with credit payment 
less than 5 years, at the year of 
purchasing between 1993 to 1997. The 
utilization rate was average at 20% of full 
capacity per year. The study did not 
estimate the total cost and cost revenue. 
PPEKI (Association of Indonesia 
Health Economists) studied about 
Utilization of Modem Medical Equipment 
in Jakarta in 1991. The objectives of this 
study was mainly to investigate and 
inventarization of modern medical 
equipment which included aspect of 
utilization and cost recovery in many 
hospitals. Using Fixed cost and Variable 
cost as cost classification. the study 
revealed that unit cost was Rp. 2.303, 
while the average charge was Rp. 3,000. 
Cost recovery of ACA studied was range 
between 35.73% to 196.21%. The 
average was 140.42%. With the high cost 
investment, end low utilization rate 
(46.41%). the patiem had to pay a high 
cost for the examination. The study did 
not show the diflerences of the cost and 
revenue In public and prhrate sector. 
A study on unit costs of laboratory 
tests was conducted by Chothiwan, eta1 
(1996). The cost was classified into capital 
cosl, material cost, and labor cost. They 
found that average charge for laboratory 
test was 33 Baht, while average unit costs 
was 26 Baht. They also found that the 
material cost was contribute the greates 
poltion (44% of total cost), whkh is 76% 
spent the expenses for the reagents. 
The cost of laboratory sewices is the 
information that must be known if  the 
facility is considering to apply usercharge 
as pan of the financing sources. The aim 
is to recover the cost of services provided 
of the full costs. However it is not fair lo 
charge the same price in public hospital 
and private hospital. Thus, it seems to be 
relevant to find the information of cost as 
well as revenue to provide a guide to 
setting the price in both facilities. 
The objective was to study the cost 
recovery of Automated Clinical Analyzer 
in a public hospilal laboratory and a 
private clinical laboratory in East Java 
province. 
Expected Benefit 
It is hoped that this study can be used 
as an input and inforrnation to policy 
maken to make appropriate decision on 
pricing policy for setting appropriate 
services charges and purchasing of 
medical technology assessment, 
especially the cost effectiveness analysis 
of new medical devices. 
Capital costs: Those costs 
concentrated at the beginning of a project 
and associated with the establishment of 
productive capacity and physical 
infrastructure. 
Cosl Recovety of Automated Clinical Analyzer 
Recurrent costs: Those costs 
associated with the operation or 
maintenance of facilities or assets. 
Revenue: The output of production 
had been sold in terms of money. 
Cost recweryratio: Ratio of cost that 
can recover from total revenue over total 
cost. 
METHODOLOGY 
study Deslgn 
This study is cross sectional 
descriptive study by collected the data 
from laboratory unit in a public hospital 
laboratory and a private clinical laboratory 
during October 1998 to September 1999. 
This study proposed to estimate the total 
mst, total revenue and the cost recovery 
of iaboratory tests of Automated Clinical 
Analyzer using capital cost and recurrent 
cost as cost classification. The study 
applied direct distribution for cost 
allocation. 
Target Population and Sampllng 
Technique of Facilities. 
Target population were public 
hospital laboratories and private clinical 
laboratories that have ACA in their 
laboratory unit. From 40 public hospitals 
and 92 private clinical laboratories, one 
sample of each institution was selected 
purposively. The selected public hospital 
wastype B public hospital, while selected 
private clinical laboratory was Type 
rrri Junl Angkasawati) 
consideratis 
Data Colle 
Utama private clinical laboratory. The 
availability of data provided become the 
on of selected faciliiies as well. 
This study collected the secondary 
data of productin cost and revenue from 
laboratory unit in public hospital and 
private clinical laboratory, which has 
Automated Clinical Analyzer to 
investigate the laboratory tests. The 
variables to be measured were number 
of laboratory tests, charge of each test. 
capital cost, material cost, maintenance 
cost and labor cost. The instrument used 
was structured questionair. 
Cost Classlflcation 
This study classified the cost by input into 
two groups (WHO, 1989): 
1) Capital cost 
These include the costs of 
construction of building, installation 
of equipment, purchase of vehicle, 
investment in human capital 
(i.e. initial training) 
2) Recurrent cost 
Typically, they include the costs of: 
Material cost: administration. 
stationery, reagents, electricity. 
water, telephone and fuel (if any). 
lor cost: Salary, fringe benefit 
l incentive! 
intenance: luipment 
and spare pan 
This study applied the direct 
distribution for cost allocation. 
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Calculation of Capltal C m  
Since we consider the economic 
cost, we have to justify the opportunity 
cost of the capital being used up. Then, 
we have to compute the capital cost by 
including the rate of inflation in the 
purchase price. All of the costs were 
calculated at 1999 price and then the 
annual costs of all capital cost items were 
calculated. To calculate the annual costs 
of all capital cost inputs, the following 
information are needed (Carryn and 
Evlo. 1995): 
Purchase p the 
year bought 
ifetime of a 
iterest rate 
"",,.li7.ti" 
rice of the assets at 
. L 1sse1s 
lr during per 
A .,. an factors 
n rate in In1 
was vary fr 
- 
lonesia du~ 
om 12.53% 
-. 
The intere: 
1991 to 1999 b 
23.32%, with average 1/.4/-/.. I ne real 
interest rate in 1999 was 15.77%, which 
was nearly the average. Thus this study 
used the interest rate 15.77%. The data 
was obtained from the Central Bank of 
Indonesia. 
Then, we should spread the amount 
of the current value over the n years of 
the lifetime of the assets, namely annual 
cost. If we consider to the amount saved 
if the value is invested in the bank at 
interest rate per year, then the annual cost 
of the capital cost can be calculated by 
using the following formula (Shepard 
er al, 
Calculation c. -,,,.,nt Coats. 
Component of recurrent cost consist 
of material cost and labor cost. The 
recurrent cost was calculate based on 
yeafly cost. Since material cost comprises 
many items so the material cost were 
calculated as price of each item muniplied 
by the total number of each material item 
used. Labor cost calculation comprises 
Salary, fringe benefit and incentives. The 
total Salary received by the labor was 
assumed that they did not work at other 
unit. The labor cost was calculated by 
adding all items of salary. 
ring Re venue Cal 
The reve 
culation 
nue of lab1 xatory test with 
AGA was calculated from the output of 
ACA utilization in laboratory unit of public 
hospital laboralory and private clinical 
laboratory. The revenue was derived by 
multiplying total number of each test with 
the charges of each test. The laboratory 
tests was tests of blood chemistry such 
as liver function tests and renal function 
tests. Assumed that all the tests was fully 
paid, without exemption of the charges. 
Lion 
~tio was def The cost 
.. .L. 
lined 
as rauo or me wsr rnal can recover $om 
total revenue over total cost. If cost 
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recovery less than one, means the the capital cost, followed by material cost 
provider is loss, on the other hand if the and labor cost. The percentage of cost 
cost recovery more than one means the )st, material cost and 
provider get profii. Cost recovery could 3%. 44.4% and 7.3% 
be computed by dividing total revenue 3ble 1). Of the capital 
over total cost. cost. 53'10 conrnouted by the cost of ACA 
(see Table 2). 
S.nsWUy Analysis In private clinical laboratory, the 
shared b 
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. --- 
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;t were 48.: 
rely (see T; 
. ... 
Sensitivity analysls was done to 
know whether the changea of variable 
used in the cost and revenue calculation 
would affect the result of calrl-"-- 
Since the two facilities have 8 
mission, then we do the se 
analysis separately. 
1) In public hospital 
The variable selected were number 
of tests and charge. Based on 
achieving break-even point can be 
regarded as worthwhile revenue and 
tests requested in public facility. In 
addition, sensif~ity anaiysis was also 
done by applied opportunity cost of 
labor cost in public hospital. 
2) In clinical laboratory 
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panern of components was the same. The 
differences was the percentage of each 
component. The cost of ACA was 
determined as the largest portion (92.9%) 
n higher than ponion 
lnd labor cost (see 
ause they have three 
macnlne ano rney use all machine to 
provide the laboratory services. 
Meanwhile, the budding cost shared the 
lowest portion because the private clinical 
laboratory use the rent building so it has 
not to pay a larger amount of initial cost. 
Material cost revealed the 
year. The 
portion of 
litles. The 
marenal wsr m prlvare cunlcal laboratory 
operatio 
reagent 
total ma1 
nal cost dl 
cost was 11 
lerial cost i 
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uring one 
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.A. .,.-:.., 
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i t  the mate1 
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ial cost mo 
. . .  
. It seem 
re etficie~ 
compare Inan material cost spent oy 
or pnvate sector. I nos sruay usea tne public hospital laboratory. The salary in 
average profit of the firm, i.e. 20% to private clinical laboratory was high 
calculate the appropriate charge. because they used the market price to 
FINDINCIS 
Component. ot Total Cost 
pay their personnel, while at public 
hospital referred to the government 
regulation. 
In public hospital laboratory. it was 
found that the highestportion of cost was 
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Table 1. Cost Sharing of Total Cosl In Public HosPMl and Prhah mratoly. 1 gS9 
Cost Item Public hospttal (Rp.) Percentage Cllnlcal l a b - t ~ . ~  rnr.) Percentage 
Capital cost 346.782.: 48.3% 450,134,518 53.5% 
Material mst 319.409.( 44.4% 266.808.M2 31.7% 
Labo 7.3% 124,200,000 14.8% 
Total 100% 841,143,161 100% 
-
r cost 
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Public hoapbl C ,, . . . - . . . - 
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Office lnvenroly 
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25.5% 
11 price (Rp) 
1.416.714 
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Chot uverase cosl 1s me cosr per unit of 
ost. 
mate 
(44% I. we 
derived three klnd of average cost. (31.43%) and capital cost (24.40%). This 
may be because they used direct and that is Average Fixed Cost (AFC). 
indirect allocation of the cost. Ussually Average Variable Cost (AVC) and Average Total Cost (ATC). The average indirect allocation cost was added to 
cost was calculated by dividing the costs, 
material cost. Meanwhile this study only i.e. fixed cosl, variable cost and total cost. 
used the direct allocation. In addition, they 
with total number of test. Basically, ATC 
obtained high material cost, because of 
tells us the per unit cvst of production. By their study determining all the cost of 
comparing the average total cost to the laboratory tests, which means a lot of price of the product, we can determine 
reagent costs included, while in this study, 
whether production is profitable or not 
only certain laboratory tests cost were (Plf 
calculated. 
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In public hospkal laboratory, it was 
found that the average fixed cost (AFC). 
average variable cost (AVC) and average 
tolal cost (ATC) of laboratory test were 
Rp. 4.071. Rp. 3.259 and Rp. 7.330 
respectively. Those average costs were 
lower than average charge (Rp. 9,220) 
(see Table 3). The average charge is the 
actual charge on average. 
In private clinical laboratory. R was 
found that average charge (Rp. 17.250) 
much higher than average total cost. The 
AFC. AVC and ATC were Rp. 9,547. 
Rp. 4,435 and Rp. 13.982 respectively. 
As a private firm which tries to maximize 
profit, it was not surprised. 
Theoretically. AFC does not 
influenced by the number of output, so 
the AFC will be higherwith low output and 
become rower with high output. The AVC 
is the function of output, the change in 
output will affect the change in variable 
cost, so the AVC will not vary in the same 
services produce. A study by PPEKl 
(1991) also indicated that the average 
services 
aborator 
asks to 
. ... 
will incret 
y equipme~ 
be autom, 
ducing in ! 
!crease in a 
charge was higher than average cost. 
The effect of inlroducing new 
medical technology will shift both the fixed 
and variable components of ATC upward. 
So the ATC for all level of medical 
! N 
I Y 
t 0 
falling average cost over aroaa ranges of 
output levels because of the low variable 
costs associated with the use of this 
equipment. The concept of economic of 
scope was playing the role in this case. It 
means that producing many kind of tests 
in the same production unit will cost less 
I n 
Iny of the in put price 
.. . 
S 
WII Increase costs. AS proaucrlon level 
increase, total variable expenditures will 
also increase. Improvements in quality 
usually cost more. The study by Wouter 
(1993) found that the number of visils and 
wages increase the total cost, but quality 
appears to reduce the cost. 
Table 3. Average Cost and Average Charge In Public Hospil 
East Java. 1999 
Total A U w  
I number d (RP) testa AFC' 
Public hmpW 
age con (RI 
AVC" 
me. Howe 
i t has allov 
ated. This 
Iver, net 
ved man 
leads 1, 
P Clinical La 
Avenge 
charge 
,.- (UP) 
Clinical 
laboratory 814,143,161 60.157 7'483 6'5W 13'983 17.250 (08%) (32%) (100%) 
= average Rxed cost 
= average variable cost 
'" = average tolal cost 
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I means tha 
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User cnarge or price 1s one or the 
sources of finance from revenue source. 
It was assumedthatthe revenue was fully 
collected and no exemption of the 
charges. It was found the total revenue 
of ACA in public hospital laboratory and 
private cl~nical laboratory were 
Rp. 883.012.80C ,219,805,000 
respe St, 
i.e. RI nd 
Rp. 64 I. I ~ J .  I o I in cllnlcal laoorarory, 
which !ar 
1999 tal 
revenue were o~talnea rrom CeRa!n tests 
such as blood glucose, total cholesterol. 
trigliceride, HDL, blood urea nitrogen, uric 
acid, total bilirubin, SGOTISGPT, total 
protein albumin and alkali phosphatas 
1 and Rp. 1 
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10.7%, they can recover the cast. The 
profit achieved In public hospital and 
clinical laboratory were 22% and 45% 
respectively. This is due to some of the 
material and labor cost received subsidy 
(in public hospital laboratory) and the 
charge of the services above the average 
unit cost (in both facilities). However, it 
does not mean that they have profit for 
long run. 
This stuc llculated the 
lomic cost arm r~nancial cost for one 
yeat loss 
and :the 
poin fed. 
The ftnding from study by PPEKl (1991) 
revealed that cost recovery ratio ranged 
between 0.35 to 2.36 with an average of 
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of total cost or operational cost. The hi! 
investment cost of capital cost should n 
be ignored when the sustainability of tl 
program was taken into consideration. 
The resuns of calculation of cost recovery 
ratio in public hospital laboratory end 
private clinical laboratory were 1.22 a1 
1.45 respectively. It means thatthey ea 
profit and cover the total cost in this yet 
With utilization rate of full capacity p,. 
year in public hospital laboratory was 
17.5% and private clinical laboratory was 
the I 
of cl 
i d  estil 
m cons 
lr. anal 
a. A m ; ,  
ly only CI 
r, meanwhi 
profit shoul 
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large on the demand aur sarvsces. If 
endfells, this may lead to an increase 
4erage cost. Even they recover only 
iall portion of total cost, the charges 
ht affect to the demand for the 
ices. 
If we con the long-run 
ainabiliof the program, the total cost 
of paying for all of its input, even those 
temporarily provided by donors or paid for 
at less then market rates, must be 
nated. Ec ,st should be 
iidered to a financial cost 
ysis as a( !formation for 
,.sion makinb. 
The result of cost r ftlo 
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invest more machine because of the 
utilization of this machine revealed 
efficiency in term of cost rec, 
However, the inefficiency in tc 
utilization rate and inequity in ecce 
source of finance of patients, must 
to become consideration before 
implementing the program. 
Concern about the equity, what will 
be the effect of the cost recovery systems 
on the health care accessibility of the poor 
people? And what mechanisms can 
ensure that the poor anc ~erable 
group will receive many 
countries, these cono led to 
measures, which exempt me poor from 
charges in order to ensure that they have 
access to health care (Carrin and Evlo. 
1995 and Newbrader. 1997). 
Senslthrih, Analysis 
l other vum 
care? In 
erns have 
. .. 
overy. 
,rm of 
ss and 
1) In public hospital 
It was found that appropriate number 
of tests at BEP was 66.950 tests 
which is 32% below the actual the 
number of tests (98.012 tests). For 
public sktor, it was no significant 
implication of break-even point 
because either they nave profit or 
loss, the services still have to be 
provided to the society. Since the aim 
is not for profit, the charge should be 
reducedto increase the demand only 
if necessary. In this case, it is 
esrll 
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OPP or 
recovc 
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oppor 
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dicate t t  
arge at BI 
I is 20% lo! 
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possible to increase the number of 
tests requested. 
The result in lat the 
appropriate chl EP was 
Rp. 7.331) which ~ e r  than 
average actual charge (Rp. 9.220). 
The facility should reduce the price 
at that point. This appropriate charge 
can also apply to provide the 
exemption charge for those who pay 
out of pocket or who cannot pay the 
services. 
Concern with the long-run 
sustainability of services providedthe 
total cost of all input must be 
"mated. In this study, the labor 
t in public hospital receives 
sidy from the government so the 
. - _ ~ r  cost is financial cost, while 
concern with economic cost or 
opporiunity cost then labor cost must 
be the same as the cost in the private 
sector or market price (Table 4). By 
applied opportunity cost of 
personnel, if they worked in private 
r, the result of estimating 
tunity cost showed that cost 
? ~ y  ratio was 1.04. It meansthat 
ost are still recover when 
3nnel is 
 led that 
alary of 
labor with consider that cost still 
recover. 
tunity cosl 
into accou 
~ l e  to incrc 
ts of perst 
nt. It rever
?ase the s 
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atlo 1 .04 - 
2) In private clinical lab0 
If the profit reduced up to 20%, the 
charge was Rp. 16.779. It was 3% 
lower then actual average charge 
(Rp. 17,250). The manager should 
readjust the charge by reducing -O'- 
e decision 
ill create m 
oernanu lor me lesrs with assurnpllon 
ate 
ne, 
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by n lor cost. The 
inve the highest 
portion or total costs. It is important 
to co fectlveness of 
this I e to invest or 
adopt it. 
Calculation of average cost tor the 
short-run revealed that average total cost 
)n msun, tt 
ned as 
-.-0 ---- 
iical labora 
st and lab 
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. .. 
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In terms of cost recovery. it was 
icated that both public hospital and 
lical laboratory had profit in 1999. 
However, it did not mean they had profit 
forthe long-run. Moreover. it is necessary 
to calculate the cast recovery for every 
year, starting from the first year of ACA 
utill 
With rega 
egulate the 
rd to equily 
pricing pol 
saty 
c y  by aqusting 
prlces or servlces provided, and 
promoting the competition in health 
services for benefit of consumers, 
according to the user characteristics in 
public hospital and clinical laboratory. 
since the cost can recover with the low 
utilization rate. For instance, the 
information of charge and the services 
should be provided to the community. 
Other mechanism to ensure efficient use 
Cost Recovev of Automated Clinical Analyzer Vri Juni Angkasawati) 
of laboratory services may be appropriate 
for referral system, which is, involves 
public and private sector for cooperative 
services as well as to ensure the alliance 
between public hospital laboratory and 
primaly health centre in district area. 
Moreover, in the public hospital 
laboratory, at break-even point the 
appropriate charge was 20% lower than 
actual charge. This should be considered 
by the policy makers to adjust the price 
to the exemption charge for the ones who 
has to pay out of pocket and the ones 
who cannot afford for the services. 
Nevertheless, government has to 
emphasize on the private sector to adjust 
the charge on the basis of the average 
profit, i.e. 20% since heakh sector is the 
area, which cannot ignore the social 
function. The reduction of charge 
suggested is based on the calculation of 
cost recovery ratio 1.20. 
However, more careful analysis of 
the effect of any production charges, 
which aim to improve technical and /or 
economic efficiency on quality of 
laboratory services, should be undertaken 
before implication. Furthermore, when 
concerning with economic cost, public 
sector should take into account all the 
resources employed, not just the ones 
they pay for. 
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